118 related articles for article (PubMed ID: 18403740)
1. Characterization of cortical microvascularization in adult moyamoya disease.
Czabanka M; Peña-Tapia P; Schubert GA; Woitzik J; Vajkoczy P; Schmiedek P
Stroke; 2008 Jun; 39(6):1703-9. PubMed ID: 18403740
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of cortical microvasculature in adult Moyamoya disease.
Czabanka M; Peña-Tapia P; Schubert GA; Woitzik J; Horn P; Schmiedek P; Vajkoczy P
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1383-7. PubMed ID: 19491920
[TBL] [Abstract][Full Text] [Related]
3. Geometrical Complexity of Cortical Microvascularization in Moyamoya Disease.
Komatsu K; Mikami T; Suzuki H; Akiyama Y; Enatsu R; Wanibuchi M; Mikuni N
World Neurosurg; 2017 Oct; 106():51-59. PubMed ID: 28666911
[TBL] [Abstract][Full Text] [Related]
4. Decreased cortical perfusion in areas with blood-brain barrier dysfunction in Moyamoya disease.
Lu X; Huang Y; Zhou P; Hui P; Wang Z
Acta Neurochir (Wien); 2020 Oct; 162(10):2565-2572. PubMed ID: 32700079
[TBL] [Abstract][Full Text] [Related]
5. Development of cortical microvascularization in Moyamoya disease using the maximum intensity projection method from three-dimensional rotational angiography.
Ito Y; Hosoo H; Marushima A; Hayakawa M; Matsumaru Y; Ishikawa E
Acta Neurochir (Wien); 2023 Mar; 165(3):605-611. PubMed ID: 36795224
[TBL] [Abstract][Full Text] [Related]
6. Neovascularization precedes occlusion in moyamoya disease: angiographic findings in 172 pediatric patients.
Kim SJ; Son TO; Kim KH; Jeon P; Hyun SH; Lee KH; Yeon JY; Kim JS; Hong SC; Shin HJ; Bang OY
Eur Neurol; 2014; 72(5-6):299-305. PubMed ID: 25323466
[TBL] [Abstract][Full Text] [Related]
7. Is Quasi-moyamoya Disease a Uniform Disease Entity? A Three-Dimensional Constructive Interference in Steady State Imaging Study.
Yamamoto S; Koh M; Kashiwazaki D; Akioka N; Kuwayama N; Noguchi K; Kuroda S
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1509-16. PubMed ID: 27038981
[TBL] [Abstract][Full Text] [Related]
8. Clinical values of intraoperative indocyanine green fluorescence video angiography with Flow 800 software in cerebrovascular surgery.
Ye X; Liu XJ; Ma L; Liu LT; Wang WL; Wang S; Cao Y; Zhang D; Wang R; Zhao JZ; Zhao YL
Chin Med J (Engl); 2013 Nov; 126(22):4232-7. PubMed ID: 24238503
[TBL] [Abstract][Full Text] [Related]
9. Perfusion characteristics of Moyamoya disease: an anatomically and clinically oriented analysis and comparison.
Schubert GA; Czabanka M; Seiz M; Horn P; Vajkoczy P; Thomé C
Stroke; 2014 Jan; 45(1):101-6. PubMed ID: 24193795
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Hemodynamic Change by Indocyanine Green-FLOW 800 Videoangiography Mapping: Prediction of Hyperperfusion Syndrome in Patients with Moyamoya Disease.
Zhang X; Ni W; Feng R; Li Y; Lei Y; Xia D; Gao P; Yang S; Gu Y
Oxid Med Cell Longev; 2020; 2020():8561609. PubMed ID: 32850003
[TBL] [Abstract][Full Text] [Related]
12. Collateralization and ischemia in hemodynamic cerebrovascular insufficiency.
Czabanka M; Acker G; Jussen D; Finger T; Pena-Tapia P; Schubert GA; Scharf J; Martus P; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2014 Nov; 156(11):2051-8; discussion 2058. PubMed ID: 25253629
[TBL] [Abstract][Full Text] [Related]
13. In vivo demonstration of blood-brain barrier impairment in Moyamoya disease.
Narducci A; Yasuyuki K; Onken J; Blecharz K; Vajkoczy P
Acta Neurochir (Wien); 2019 Feb; 161(2):371-378. PubMed ID: 30675657
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic reserve and high-intensity transient signals in moyamoya disease.
Horn P; Lanczik O; Vajkoczy P; Daffertshofer M; Bueltmann E; Werner A; Schmiedek P; Hennerici M
Cerebrovasc Dis; 2005; 19(3):141-6. PubMed ID: 15644625
[TBL] [Abstract][Full Text] [Related]
15. Microscope-integrated quantitative analysis of intraoperative indocyanine green fluorescence angiography for blood flow assessment: first experience in 30 patients.
Kamp MA; Slotty P; Turowski B; Etminan N; Steiger HJ; Hänggi D; Stummer W
Neurosurgery; 2012 Mar; 70(1 Suppl Operative):65-73; discussion 73-4. PubMed ID: 21811190
[TBL] [Abstract][Full Text] [Related]
16. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya, unilateral to bilateral in one year.
Veselinovic N; Zidverc-Trajkovic J; Semnic R; Tomic G; Sternic N; Bjelan M
Vasa; 2014 Jul; 43(4):284-6. PubMed ID: 25007907
[No Abstract] [Full Text] [Related]
18. Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change.
Jeon JS; Ahn JH; Moon YJ; Cho WS; Son YJ; Kim SK; Wang KC; Bang JS; Kang HS; Kim JE; Oh CW
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):726-31. PubMed ID: 24292994
[TBL] [Abstract][Full Text] [Related]
19. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
[TBL] [Abstract][Full Text] [Related]
20. High-resolution MR imaging of the arterial wall in moyamoya disease.
Yuan M; Liu ZQ; Wang ZQ; Li B; Xu LJ; Xiao XL
Neurosci Lett; 2015 Jan; 584():77-82. PubMed ID: 25459282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
